The distributions of ABAT and ALDH6A1 in ccRCC clinical tissues were screened by reverse transcription-quantitative polymerase chain reaction (RT-QPCR) and immunohistochemical assays. This evidence concerns the gene ALDH6A1 and nonpapillary renal cell carcinoma.